RELUGOLIX, ESTRADIOL HEMIHYDRATE, AND NORETHINDRONE ACETATE

RELUGOLIX, ESTRADIOL HEMIHYDRATE, AND NORETHINDRONE ACETATE was reported 1516 times

RELUGOLIX, ESTRADIOL HEMIHYDRATE, AND NORETHINDRONE ACETATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 UTERINE LEIOMYOMA NECROSIS 2 0.2500
1 UTERINE LEIOMYOMA PROLAPSE 1 0.2000
2 UTERINE NECROSIS 1 0.0417
3 THYROXINE FREE ABNORMAL 3 0.0375
4 MYOMECTOMY 5 0.0352
5 ABNORMAL MENSTRUAL CLOTS 6 0.0343
6 HEAVY MENSTRUAL BLEEDING 233 0.0259
7 INTERMENSTRUAL BLEEDING 118 0.0211
8 ANTI-MUELLERIAN HORMONE LEVEL DECREASED 1 0.0172
9 FALLOPIAN TUBE OBSTRUCTION 1 0.0143
10 MENSTRUAL CLOTS 3 0.0125
11 OVULATION PAIN 2 0.0095
12 ADHESIOLYSIS 1 0.0093
13 MENSTRUAL DISCOMFORT 1 0.0083
14 SWEAT GLAND INFECTION 1 0.0079
15 PREMENSTRUAL PAIN 1 0.0076
16 POLYMENORRHOEA 23 0.0066
17 THERAPY INTERRUPTED 472 0.0066
18 UTERINE OPERATION 1 0.0065
19 ABNORMAL UTERINE BLEEDING 16 0.0062
20 HAEMATOLOGY TEST ABNORMAL 2 0.0062
21 OVARIAN CYSTECTOMY 1 0.0055
22 ANOVULATORY CYCLE 1 0.0048
23 LAPAROSCOPIC SURGERY 1 0.0046
24 DYSMENORRHOEA 60 0.0045
25 BLOOD OESTROGEN DECREASED 3 0.0043
26 BLOOD LUTEINISING HORMONE INCREASED 1 0.0041
27 ENDOMETRIAL THICKENING 2 0.0036
28 SPLENIC HAEMATOMA 1 0.0035
29 MENSTRUAL DISORDER 28 0.0034
30 VAGINAL FLATULENCE 1 0.0033
31 ADNEXA UTERI PAIN 4 0.0031
32 IODINE ALLERGY 1 0.0030
33 UTERINE PAIN 3 0.0029
34 OLIGOMENORRHOEA 6 0.0027
35 HER2 POSITIVE BREAST CANCER 1 0.0027
36 OVARIAN ENLARGEMENT 1 0.0026
37 CEREBELLAR STROKE 1 0.0026
38 SCAR PAIN 1 0.0025
39 UTERINE MASS 1 0.0024
40 MENSTRUATION IRREGULAR 62 0.0023
41 ENDOMETRIOSIS 11 0.0023
42 PERINATAL DEPRESSION 1 0.0022
43 CHLOASMA 1 0.0022
44 MENOPAUSAL SYMPTOMS 5 0.0021
45 UTERINE CERVIX STENOSIS 1 0.0019
46 BLOOD INSULIN INCREASED 1 0.0018
47 SALPINGECTOMY 1 0.0017
48 MORBID THOUGHTS 2 0.0017
49 BLOOD OESTROGEN INCREASED 1 0.0017
50 INTRUSIVE THOUGHTS 2 0.0017
51 ADENOMYOSIS 1 0.0017
52 UTERINE LEIOMYOMA 12 0.0016
53 BLOOD THYROID STIMULATING HORMONE ABNORMAL 3 0.0016
54 PREMENSTRUAL SYNDROME 2 0.0015
55 INSURANCE ISSUE 22 0.0014
56 PELVIC FLUID COLLECTION 1 0.0014
57 INTRAOCULAR PRESSURE TEST ABNORMAL 1 0.0014
58 THYROXINE INCREASED 1 0.0014
59 HYSTERECTOMY 12 0.0014
60 UTERINE ENLARGEMENT 1 0.0013
61 AMENORRHOEA 22 0.0013
62 SUPERFICIAL VEIN THROMBOSIS 1 0.0012
63 UTERINE HAEMORRHAGE 5 0.0012
64 UTERINE POLYP 2 0.0011
65 UTERINE SPASM 2 0.0011
66 DRUG DISPENSED TO WRONG PATIENT 1 0.0010
67 AFFECTIVE DISORDER 8 0.0010
68 DRUG EXPOSURE BEFORE PREGNANCY 1 0.0010
69 NIPPLE PAIN 2 0.0010
70 BREAST DISCOMFORT 1 0.0010
71 HOT FLUSH 70 0.0009
72 SUPERFICIAL INJURY OF EYE 1 0.0009
73 HALO VISION 1 0.0009
74 PRODUCT DISTRIBUTION ISSUE 8 0.0009
75 UTERINE DISORDER 2 0.0009
76 DEPRESSIVE SYMPTOM 3 0.0009
77 MOOD SWINGS 27 0.0008
78 HORMONE LEVEL ABNORMAL 4 0.0008
79 ALLERGY TO CHEMICALS 1 0.0008
80 BREAST TENDERNESS 6 0.0008
81 VAGINAL ODOUR 1 0.0008
82 FEELINGS OF WORTHLESSNESS 1 0.0008
83 OFF LABEL USE OF DEVICE 1 0.0007
84 MIGRAINE WITH AURA 2 0.0007
85 HYPOMENORRHOEA 2 0.0007
86 TRICHORRHEXIS 2 0.0007
87 THERAPEUTIC PROCEDURE 1 0.0007
88 PRECANCEROUS CELLS PRESENT 1 0.0007
89 LABELLED DRUG-DRUG INTERACTION ISSUE 1 0.0007
90 COITAL BLEEDING 1 0.0006
91 BACTERIAL VAGINOSIS 1 0.0006
92 VULVOVAGINAL DRYNESS 2 0.0006
93 BREAST ENLARGEMENT 2 0.0006
94 CONTRAINDICATED PRODUCT PRESCRIBED 1 0.0006
95 SLEEP TALKING 1 0.0006
96 BREAST PAIN 6 0.0006
97 NARCOLEPSY 1 0.0005
98 NIGHT SWEATS 17 0.0005
99 HEPATIC MASS 1 0.0005
100 MOOD ALTERED 14 0.0005
101 CARDIAC DISCOMFORT 1 0.0005
102 LIBIDO INCREASED 1 0.0005
103 BREAST DISORDER 1 0.0005
104 DRUG EFFECT LESS THAN EXPECTED 7 0.0005
105 MENSTRUATION DELAYED 5 0.0005
106 HAEMOGLOBIN INCREASED 2 0.0004
107 BRAIN OPERATION 1 0.0004
108 DYSPAREUNIA 2 0.0004
109 BREAKTHROUGH PAIN 1 0.0004
110 TRANSPLANT 1 0.0004
111 INCORRECT DOSAGE ADMINISTERED 2 0.0004
112 EYE OEDEMA 1 0.0004
113 INABILITY TO AFFORD MEDICATION 4 0.0004
114 OSTEOPENIA 6 0.0004
115 VAGINAL DISCHARGE 4 0.0004
116 PRODUCT PACKAGING DIFFICULT TO OPEN 1 0.0004
117 BRAIN FOG 6 0.0004
118 PERSONALITY DISORDER 1 0.0004
119 SHOULDER ARTHROPLASTY 1 0.0004
120 VAGINAL HAEMORRHAGE 16 0.0004
121 INVASIVE DUCTAL BREAST CARCINOMA 1 0.0004
122 CHOLECYSTITIS INFECTIVE 1 0.0004
123 ELECTRIC SHOCK SENSATION 1 0.0004
124 ALOPECIA 68 0.0003
125 WRONG PATIENT RECEIVED PRODUCT 1 0.0003
126 LOSS OF LIBIDO 3 0.0003
127 ACNE CYSTIC 1 0.0003
128 BREAST MASS 2 0.0003
129 DEEP VEIN THROMBOSIS 19 0.0003
130 EMOTIONAL DISORDER 9 0.0003
131 SUICIDAL IDEATION 26 0.0003
132 HYPERACUSIS 1 0.0003
133 BONE DENSITY ABNORMAL 1 0.0003
134 HAEMORRHAGE 27 0.0003
135 POLYDIPSIA 1 0.0003
136 FURUNCLE 2 0.0003
137 HYPERPHAGIA 1 0.0003
138 ENURESIS 1 0.0002
139 MATERNAL EXPOSURE DURING BREAST FEEDING 1 0.0002
140 INCORRECT DRUG ADMINISTRATION RATE 1 0.0002
141 PRODUCT DISPENSING ISSUE 1 0.0002
142 HEPATIC LESION 1 0.0002
143 URINARY TRACT DISORDER 1 0.0002
144 PAPILLOEDEMA 1 0.0002
145 PELVIC PAIN 4 0.0002
146 THERAPEUTIC PRODUCT EFFECT DELAYED 1 0.0002
147 IRON DEFICIENCY ANAEMIA 2 0.0002
148 FLANK PAIN 2 0.0002
149 DEPRESSED MOOD 11 0.0002
150 AFFECT LABILITY 2 0.0002
151 PHARYNGEAL SWELLING 2 0.0002
152 ABDOMINAL TENDERNESS 1 0.0002
153 OVARIAN CYST 2 0.0002
154 BONE LOSS 3 0.0002
155 VULVOVAGINAL PRURITUS 1 0.0002
156 TRANSFUSION 2 0.0002
157 GASTROINTESTINAL MOTILITY DISORDER 1 0.0002
158 BRUXISM 1 0.0002
159 INTRACRANIAL PRESSURE INCREASED 1 0.0002
160 MIGRAINE 17 0.0002
161 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 32 0.0002
162 FEELING OF BODY TEMPERATURE CHANGE 1 0.0002
163 URINE ODOUR ABNORMAL 1 0.0002
164 GLUCOSE TOLERANCE IMPAIRED 1 0.0002
165 BLOOD IRON DECREASED 2 0.0002
166 CYST 2 0.0002
167 NASAL DRYNESS 1 0.0002
168 BLEPHAROSPASM 1 0.0002
169 PULMONARY EMBOLISM 15 0.0002
170 SCREAMING 1 0.0002
171 HAEMOGLOBIN DECREASED 16 0.0002
172 CARDIAC FLUTTER 1 0.0002
173 BONE PAIN 9 0.0002
174 SURGERY 9 0.0002
175 BRADYPHRENIA 1 0.0002
176 SOMNAMBULISM 1 0.0002
177 PRODUCT FORMULATION ISSUE 1 0.0002
178 METASTASES TO LYMPH NODES 1 0.0001
179 ONYCHOCLASIS 1 0.0001
180 DEPRESSION 33 0.0001
181 HAIR GROWTH ABNORMAL 1 0.0001
182 PAPULE 1 0.0001
183 MUSCLE SPASMS 26 0.0001
184 RETINAL HAEMORRHAGE 1 0.0001
185 VISUAL FIELD DEFECT 1 0.0001
186 CRYING 5 0.0001
187 SENSITIVE SKIN 1 0.0001
188 GENERAL SYMPTOM 1 0.0001
189 DISSOCIATION 1 0.0001
190 SWOLLEN TONGUE 4 0.0001
191 BONE DENSITY DECREASED 4 0.0001
192 ELECTROCARDIOGRAM ABNORMAL 1 0.0001
193 UTERINE CANCER 1 0.0001
194 POST PROCEDURAL INFECTION 1 0.0001
195 ANGER 4 0.0001
196 HEADACHE 74 0.0001
197 BLOOD PRESSURE INCREASED 18 0.0001
198 INADEQUATE ANALGESIA 1 0.0001
199 SCAR 2 0.0001
200 WEIGHT INCREASED 26 0.0001
201 NAIL DISORDER 1 0.0001
202 SPINAL OSTEOARTHRITIS 1 0.0001
203 THIRST 2 0.0001
204 THROMBOSIS 9 0.0001
205 ANAL INCONTINENCE 1 0.0001
206 PALPITATIONS 13 0.0001
207 INCREASED TENDENCY TO BRUISE 1 0.0001
208 SPINAL DISORDER 1 0.0001
209 INCREASED APPETITE 2 0.0001
210 VITREOUS FLOATERS 1 0.0001
211 HAEMATOCRIT DECREASED 2 0.0001
212 SALIVARY HYPERSECRETION 1 0.0001
213 FULL BLOOD COUNT DECREASED 2 0.0001
214 FEELING HOT 6 0.0001
215 HELICOBACTER INFECTION 1 0.0001
216 PRODUCT ODOUR ABNORMAL 1 0.0001
217 POOR QUALITY PRODUCT ADMINISTERED 1 0.0001
218 HYPERHIDROSIS 12 0.0001
219 BREAST CANCER METASTATIC 1 0.0001
220 ACNE 7 0.0001
221 BIPOLAR DISORDER 1 0.0001
222 MENTAL DISORDER 4 0.0001
223 PRODUCT PRESCRIBING ISSUE 2 0.0001
224 PULMONARY THROMBOSIS 1 0.0001
225 TOOTH FRACTURE 1 0.0001
226 OCULAR DISCOMFORT 1 0.0001
227 ANXIETY 25 0.0001
228 MICTURITION URGENCY 1 0.0001
229 CHOLECYSTECTOMY 1 0.0001
230 NIGHTMARE 3 0.0001
231 CHOLECYSTITIS 1 0.0001
232 IRRITABILITY 5 0.0001
233 ABDOMINAL PAIN UPPER 17 0.0001
234 NOCTURIA 1 0.0001
235 PANIC ATTACK 3 0.0001
236 OFF LABEL USE 72 0.0001
237 PHARYNGITIS 1 0.0001
238 GLYCOSYLATED HAEMOGLOBIN INCREASED 2 0.0001
239 INTRAOCULAR PRESSURE INCREASED 1 0.0001
240 ILLNESS 8 0.0001
241 DIPLOPIA 2 0.0001
242 NODULE 1 0.0001
243 IMMUNE SYSTEM DISORDER 1 0.0001
244 EAR INFECTION 2 0.0001
245 PRODUCT DOSE OMISSION ISSUE 22 0.0001
246 HAIR TEXTURE ABNORMAL 1 0.0001
247 FEAR 2 0.0001
248 DISTURBANCE IN ATTENTION 4 0.0001
249 SINUS CONGESTION 1 0.0001
250 PRODUCT TASTE ABNORMAL 1 0.0001
251 HYPOAESTHESIA 11 0.0001
252 PAIN 45 0.0001
253 DEVICE OCCLUSION 1 0.0001
254 HYPERTENSION 15 0.0001
255 HEART RATE INCREASED 7 0.0001
256 SEASONAL ALLERGY 1 0.0001
257 PRODUCT DOSE OMISSION IN ERROR 2 0.0001
258 INTENTIONAL DOSE OMISSION 2 0.0001
259 ABDOMINAL PAIN 16 0.0001
260 APATHY 1 0.0001
261 URINARY INCONTINENCE 2 0.0001
262 HYPOAESTHESIA ORAL 1 0.0001
263 VISION BLURRED 9 0.0001
264 SKIN DISCOLOURATION 3 0.0001
265 INJECTION SITE RASH 2 0.0001
266 CHEST PAIN 12 0.0001
267 BACK PAIN 15 0.0001
268 NAUSEA 51 0.0001
269 BLOOD CHOLESTEROL INCREASED 3 0.0001
270 SCIATICA 1 0.0001
271 HYPOTHYROIDISM 2 0.0001
272 MUSCLE TIGHTNESS 1 0.0001
273 BACK DISORDER 1 0.0001
274 SWELLING FACE 4 0.0001
275 LIP SWELLING 2 0.0001
276 FUNGAL INFECTION 2 0.0001
277 SKIN DISORDER 2 0.0001
278 PRODUCT USE ISSUE 11 0.0001
279 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 1 0.0001
280 PAIN IN EXTREMITY 17 0.0001
281 ABDOMINAL DISTENSION 6 0.0001
282 DEVICE USE ISSUE 1 0.0001
283 COLD SWEAT 1 0.0001
284 ADVERSE DRUG REACTION 5 0.0001
285 TOOTHACHE 1 0.0001
286 BONE DISORDER 1 0.0001
287 DYSURIA 2 0.0001
288 ADVERSE EVENT 5 0.0001
289 THINKING ABNORMAL 1 0.0001
290 BLISTER 3 0.0001
291 DYSARTHRIA 2 0.0001
292 FEELING JITTERY 1 0.0001
293 SLEEP APNOEA SYNDROME 1 0.0001
294 PERIPHERAL SWELLING 8 0.0001
295 EAR PAIN 1 0.0001
296 BLOOD PRESSURE ABNORMAL 1 0.0001
297 COMPLICATION OF DEVICE INSERTION 1 0.0001
298 UPPER LIMB FRACTURE 1 0.0001
299 PREGNANCY 1 0.0000
300 FEEDING DISORDER 1 0.0000
301 URTICARIA 8 0.0000
302 RETCHING 1 0.0000
303 IMPAIRED WORK ABILITY 1 0.0000
304 IRRITABLE BOWEL SYNDROME 1 0.0000
305 DIZZINESS 23 0.0000
306 PRODUCT DISPENSING ERROR 1 0.0000
307 THERAPEUTIC PRODUCT EFFECT DECREASED 2 0.0000
308 SNEEZING 1 0.0000
309 CHROMATURIA 1 0.0000
310 HEART RATE IRREGULAR 1 0.0000
311 PRODUCT AVAILABILITY ISSUE 1 0.0000
312 RASH 19 0.0000
313 BREAST CANCER 4 0.0000
314 SLEEP DISORDER 3 0.0000
315 NEURALGIA 1 0.0000
316 AGITATION 3 0.0000
317 VISUAL IMPAIRMENT 5 0.0000
318 ABDOMINAL PAIN LOWER 1 0.0000
319 PRODUCT COMPLAINT 1 0.0000
320 CARDIOVASCULAR DISORDER 1 0.0000
321 FLUSHING 4 0.0000
322 THERAPY CESSATION 2 0.0000
323 FATIGUE 30 0.0000
324 RESPIRATORY TRACT INFECTION 1 0.0000
325 PARAESTHESIA 6 0.0000
326 GASTRITIS 1 0.0000
327 INSOMNIA 10 0.0000
328 BREAST CANCER FEMALE 1 0.0000
329 DRY MOUTH 3 0.0000
330 RASH PRURITIC 2 0.0000
331 OEDEMA 2 0.0000
332 PALLOR 1 0.0000
333 FEELING COLD 1 0.0000
334 NECK PAIN 2 0.0000
335 EYE PAIN 2 0.0000
336 LIVER FUNCTION TEST ABNORMAL 1 0.0000
337 DYSSTASIA 1 0.0000
338 ARTHRALGIA 14 0.0000
339 CONTRAINDICATED PRODUCT ADMINISTERED 1 0.0000
340 LIMB DISCOMFORT 1 0.0000
341 ANAEMIA 6 0.0000
342 CYSTITIS 1 0.0000
343 DRUG INEFFECTIVE 40 0.0000
344 URINARY RETENTION 1 0.0000
345 INJECTION SITE PRURITUS 2 0.0000
346 EYE PRURITUS 1 0.0000
347 MALAISE 13 0.0000
348 CEREBROVASCULAR ACCIDENT 5 0.0000
349 HEPATIC ENZYME INCREASED 2 0.0000
350 CHEST DISCOMFORT 3 0.0000
351 ASTHENIA 11 0.0000
352 FEELING ABNORMAL 7 0.0000
353 RASH MACULAR 1 0.0000
354 BURNING SENSATION 2 0.0000
355 COVID-19 5 0.0000
356 DYSPNOEA 16 0.0000
357 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 2 0.0000
358 VOMITING 13 0.0000
359 ACCIDENTAL OVERDOSE 1 0.0000
360 EYE SWELLING 1 0.0000
361 DYSPNOEA EXERTIONAL 1 0.0000
362 UNEVALUABLE EVENT 2 0.0000
363 DISORIENTATION 1 0.0000
364 INJECTION SITE BRUISING 2 0.0000
365 ABORTION SPONTANEOUS 1 0.0000
366 GASTROOESOPHAGEAL REFLUX DISEASE 2 0.0000
367 EMOTIONAL DISTRESS 3 0.0000
368 BLINDNESS 1 0.0000
369 OSTEOPOROSIS 1 0.0000
370 TREATMENT FAILURE 2 0.0000
371 POLLAKIURIA 1 0.0000
372 WITHDRAWAL SYNDROME 1 0.0000
373 MYALGIA 4 0.0000
374 PRODUCT STORAGE ERROR 2 0.0000
375 TACHYCARDIA 2 0.0000
376 THERAPEUTIC RESPONSE UNEXPECTED 1 0.0000
377 INCORRECT DOSE ADMINISTERED 5 0.0000
378 MEMORY IMPAIRMENT 3 0.0000
379 CARDIAC DISORDER 2 0.0000
380 SWELLING 2 0.0000
381 OCULAR HYPERAEMIA 1 0.0000
382 DYSPHAGIA 2 0.0000
383 DRY EYE 1 0.0000
384 MUSCULOSKELETAL PAIN 1 0.0000
385 PANCREATITIS 1 0.0000
386 ASPARTATE AMINOTRANSFERASE INCREASED 1 0.0000
387 CONSTIPATION 4 0.0000
388 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
389 ANAPHYLACTIC REACTION 1 0.0000
390 EYE IRRITATION 1 0.0000
391 SEIZURE 2 0.0000
392 CHILLS 2 0.0000
393 NASAL CONGESTION 1 0.0000
394 DISCOMFORT 1 0.0000
395 ALANINE AMINOTRANSFERASE INCREASED 1 0.0000
396 EXPOSURE DURING PREGNANCY 1 0.0000
397 LOSS OF CONSCIOUSNESS 2 0.0000
398 RHINORRHOEA 1 0.0000
399 AMNESIA 1 0.0000
400 DEHYDRATION 2 0.0000
401 BRONCHITIS 1 0.0000
402 EPISTAXIS 1 0.0000
403 HALLUCINATION 1 0.0000
404 DECREASED APPETITE 3 0.0000
405 ARTHRITIS 1 0.0000
406 INFLUENZA LIKE ILLNESS 1 0.0000
407 GASTROINTESTINAL HAEMORRHAGE 1 0.0000
408 ABDOMINAL DISCOMFORT 2 0.0000
409 SKIN EXFOLIATION 1 0.0000
410 PYREXIA 4 0.0000
411 MUSCULOSKELETAL STIFFNESS 1 0.0000
412 GASTROINTESTINAL DISORDER 1 0.0000
413 DEVICE ISSUE 1 0.0000
414 NASOPHARYNGITIS 2 0.0000
415 DIARRHOEA 7 0.0000
416 OROPHARYNGEAL PAIN 1 0.0000
417 HYPERSENSITIVITY 2 0.0000
418 WEIGHT DECREASED 3 0.0000
419 COUGH 3 0.0000
420 BLOOD GLUCOSE INCREASED 2 0.0000
421 PRURITUS 4 0.0000
422 CONTUSION 1 0.0000
423 SOMNOLENCE 2 0.0000
424 SINUSITIS 1 0.0000
425 MUSCULAR WEAKNESS 1 0.0000
426 JOINT SWELLING 1 0.0000
427 PRODUCT USE IN UNAPPROVED INDICATION 2 0.0000
428 DRY SKIN 1 0.0000
429 PRODUCT QUALITY ISSUE 1 0.0000
430 INJECTION SITE PAIN 2 0.0000
431 CONFUSIONAL STATE 1 0.0000
432 URINARY TRACT INFECTION 1 0.0000
433 MYOCARDIAL INFARCTION 1 0.0000
434 GAIT DISTURBANCE 1 0.0000
435 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1 0.0000
436 ERYTHEMA 1 0.0000